HCM HUTCHMED (China) Limited
Healthcare$11.75-2.00%ClosedMarket Cap: $2.05B
As of 2026-05-26
Valuation
P/E (TTM)
5.90
PEG
0.00
P/B
19.92
P/S
3.84
EV/EBITDA
-82.40
DCF Value
$-67.56
FCF Yield
-3.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
11.6%
Operating Margin
-7.1%
Net Margin
83.3%
ROE
37.0%
ROA
26.1%
ROIC
-2.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY null | $550.0M | 38.7% | $-54.7M | $458.1M | $— | — |
| Q2 null | $138.8M | 39.7% | $-1.8M | $227.5M | $— | — |
| Q1 null | $138.8M | 39.7% | $-1.8M | $227.5M | $— | — |
| Q4 null | $162.3M | -17.4% | $-8.1M | $6.0M | $— | — |
| FY null | $630.2M | 44.6% | $-43.7M | $37.7M | $— | — |
| Q3 null | $162.3M | -17.4% | $-8.1M | $6.0M | $— | — |
| Q2 null | $152.8M | 41.1% | $-13.8M | $12.9M | $— | — |
| Q1 null | $152.8M | 41.1% | $-13.8M | $12.9M | $— | — |
| Q4 null | $152.6M | 93.9% | $-46.6M | $-33.9M | $— | — |
| FY null | $838.0M | 54.1% | $18.4M | $100.8M | $— | — |
| Q3 null | $152.6M | -56.7% | $-46.6M | $-33.9M | $— | — |
| Q2 2023 | $266.4M | 60.9% | $55.8M | $84.3M | $0.49 | — |